about
Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maravirocSafety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial
P50
description
researcher (ORCID 0000-0002-4677-6782)
@en
wetenschapper
@nl
name
Peter A Anton
@en
Peter A Anton
@nl
type
label
Peter A Anton
@en
Peter A Anton
@nl
prefLabel
Peter A Anton
@en
Peter A Anton
@nl
P31
P496
0000-0002-4677-6782